HIV in adolescents: What we know and what we need to know

Current Psychiatry Reports

Volumn 10, Issue 2, 2008, Pages 109-115

  Benton, Tami D ^a   Ifeagwu, Judith A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PROTEINASE INHIBITOR; PSYCHOSTIMULANT AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR; SERTRALINE; PSYCHOTROPIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD BEHAVIOR; CHILD HOSPITALIZATION; CHILD PSYCHIATRY; DEPRESSION; DRUG SAFETY; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROTOXICITY; PATIENT ATTITUDE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEXUAL ABUSE; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ADULT; BEHAVIOR THERAPY; COGNITIVE DEFECT; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; FEMALE; MALE; MENTAL DISEASE; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; UNSAFE SEX;

ADOLESCENT; ADULT; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BEHAVIOR THERAPY; COGNITION DISORDERS; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENTAL DISORDERS; PSYCHOTROPIC DRUGS; UNSAFE SEX;

EID: 49649125881     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-008-0020-7     Document Type: Review

References (43)

1. US Department of Health and Human Services, Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report 2003, vol 15. Atlanta: Centers for Disease Control and Prevention; 2004:1-40. http://www.cdc.gov/hiv/stats/hasrlink.htm Accessed January 14, 2008.
2. US Department of Health and Human Services, Centers for Disease Control and Prevention: HIV/AIDS among youth. In HIV/AIDS Surveillance Report 2004, vol 16. Atlanta: Centers for Disease Control and Prevention; 2005:1-46. http://www.cdc.gov/hiv/topics/surveillance/ resources/reports/2004report. Accessed January 14, 2008.
3. Evans DL, Ten Have TR, Douglas SD, et al.: Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 2002, 159:1752-1759.
4. Morrison MF, Petitto JM, Ten Have T, et al.: Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry 2002, 159:789-796.
5. Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
6. Fauci A, Lane HC: HIV disease: AIDS and related disorders. In Harrison's Principles of Internal Medicine, edn 15. Edited by Braunwald E. New York: McGraw-Hill; 2001:1852-1913.
7. Grunbaum JA, Kann L, Kinchen S, et al.: Youth risk behavior surveillance - United States, 2003. MMWR Surveill Summ 2004, 53:1-96.
8. Lehrer JA, Shrier LA, Gortmaker S: Depressive symptoms as a longitudinal predictor of sexual risk behaviors among US middle and high school students. Pediatrics 2006, 118:189-200.
9. Leserman J: HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry 2003, 54:295-306.
10. Murphy DA, Durako SJ, Moscicki AB, et al.: No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. J Adolesc Health 2001, 29(3 Suppl):57-63.
11. Lightfoot M, Swendeman D, Rotheram-Borus MJ, et al.: Risk behaviors of youth living with HIV: pre- and post-HAART. Am J Health Behav 2005, 29:162-171.
12. Murphy DA, Mosciki B, Vermund SH: Psychological distress among HIV+ adolescents in the REACH study: effects of life stress, social support and coping. J Adolesc Health 2000, 27:391-398.
13. Hein K, Dell K, Rotheram-Borus MJ, et al.: Comparison of HIV+ and HIV- adolescents: risk factors and psychosocial determinants. Pediatrics 1995, 95:96-104.
14. Donenberg G, Pao M: Youths and HIV/AIDS: psychiatry's role in a changing epidemic. J Am Acad Child Adolesc Psychiatry 2005, 44:728-747.
15. Donenberg G, Pao M: Understanding HIV/AIDS: psychosocial and psychiatric issues in youths. Contemp Psychiatry 2003, 2:1-8.
16. Brown LK, Lescano CM, Lourie KJ: Children and adolescents with HIV infection. Psychiatr Ann 2001, 31:63-68.
17. Lwin R, Melvin D: Paediatric HIV infection. J Child Psychol Psychiatry 2001, 42:427-438.
18. Mellins CA, Smith R, O'Driscoll P, et al.: High rates of behavioral problems in perinatally HIV-infected children are not linked to HIV disease. Pediatrics 2003, 111:384-393.
19. Scharko AM: DSM psychiatric disorders in the context of pediatric HIV/ AIDS. AIDS Care 2006, 18:441-445.
20. Misdrahi D, Vila G, Funk-Brentano I, et al.: DSM-IV mental disorders and neurological complications in children and adolescents with human immunodeficiency virus type infection (HIV-1). Eur Psychiatry 2004, 19:182-184.
21. Gaughan DM, Hughes MD, Oleske JM, et al.: Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics 2004, 113: E544-E551.
22. Tardieu M, Chenadec JL, Persoz A: HIV-1-related encephalopathy in infants compared with children and adults. French Pediatric HIV Infection Study and the SEROCO group. Neurology 2000, 54:1089-1095.
23. Watkins JM, Cool VA, Usner D, et al.: Attention in HIV-infected children: results from the Hemophilia Growth and Development Study. J Int Neuropsychol Soc 2000, 6:443-454.
24. Brown LK, Danokovsy MB, Lourie KJ: Adolescents with psychiatric disorders and the risk of HIV. J Am Acad Child Adolesc Psychiatry 1997, 36:1609-1617.
25. DiClemente RJ, Ponton LE: HIV-related risk behaviors among psychiatrically hospitalized adolescents and school-based adolescents. Am J Psychiatry 1993, 150:324-325.
26. Deas-Nesmith D, Brady KT, White R, et al.: HIV-risk behaviors in adolescent substance abusers. J Subst Abuse Treat 1999, 16:169-172.
27. Tubman JG, Gil AG, Wagner EF, et al.: Patterns of sexual risk behaviors and psychiatric disorders in a community sample of young adults. J Behav Med 2003, 26:473-500.
28. Rotheram-Borus MJ, Mahler KA, Rosario M: AIDS prevention with adolescents. AIDS Educ Prev 1995, 7:320-336.
29. Booth RE, Zhang YH: Conduct disorder and HIV risk behaviors among runaway and homeless adolescents. Drug Alcohol Depend 1997, 48:69-76.
30. Donenberg GR, Emerson E, Bryant FB, et al.: Understanding AIDS-risk behavior among adolescents in psychiatric care: links to psychopathology and peer relationships. J Am Acad Child Adolesc Psychiatry 2001, 40:642-653.
31. Brown L, Lourie K, Zlotnik C, et al.: Impact of sexual abuse on the HIV-related behavior of adolescents in intensive psychiatric treatment. Am J Psychiatry 2000, 157:1413-1415.
32. Guttmann LT, Herman-Giddens ME, McKinney RE, et al.: Pediatric acquired immunodeficiency syndrome: barriers to recognizing the role of child sexual abuse. Am J Dis Child 1993, 147:775-780.
33. Lindgren ML, Hanson IC, Hammett TA, et al.: Sexual abuse of children: intersection with the HIV epidemic. Pediatrics 1998, 102:E46.
34. Lodico MA, DiClemente RJ: The association between childhood sexual abuse and prevalence of HIV-related risk behaviors. Clin Pediatr (Phila) 1994, 33:498-502.
35. Murphy DA, Belzer M, Durako SJ, et al.: Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 2005, 159:764-770.
36. Williams PL, Storm D, Montepiedra G, et al.: Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics 2006, 118:e1745-e1757.
37. Weiner L, Battles H, Ryder C, et al.: Psychotropic medication use in human immunodeficiency virus-infected youth receiving treatment at a single institution. J Child Adolesc Psychopharmacol 2006, 16:747-753.
38. Evans DL, Charney DS, Lewis L, et al.: Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58:175-189.
39. Dube B, Benton T, Cruess DG, Evans DL: Neuropsychiatric manifestations of HIV infection and AIDS. J Psychiatry Neurosci 2005, 30:237-246.
40. Pieper AA, Treisman GJ: Drug treatment of depression in HIV-positive patients: safety considerations. Drug Saf 2005, 28:753-762.
41. Leserman J, DiSantostefano BS, Perkins DO: A longitudinal study of social support, and social conflict as predictors of depression and dysphoria among HIV-positive and HIV-negative gay men. Depression 1994, 2:189-199.
42. Cruess DG, Douglas SD, Petitto JM, et al.: Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am J Psychiatry 2005, 162:2125-2130.
43. Douglas SD, Camarco M, Xu J, et al.: The relationships between substance abuse, psychosocial variables, and natural killer cell enumeration and function in HIV infected and high-risk uninfected adolescents. AIDS Res Hum Retroviruses 2003, 19:399-408.